Abstract
In the prevailing era of cardiovascular and chronic diseases, the causes of death seldom operate in isolation. We aim to assess the impact of distortions in statistically significant associations between causes of death on the overall structure of cause of death dependencies. Focusing on the causes of death for USA in 2019, we study all possible scenarios for independence of diseases by optimizing the marginal distributions in the respective contingency tables. We select the independence scenario that corresponds to the minimal intervention in the contingency table and study the effect of setting up independence between diseases i and j on the relationships between i and k (or j and k). Disrupting associations between leading cause of death pairs would generally lead to decreases in the strength of relations these diseases have with others outside the disrupted pair. The most pronounced effects are observed in the loss of association between mental and behavioral disorders with other respiratory diseases; heart diseases with endocrine, nutritional, and metabolic disorders; and heart diseases with mental and behavioral disorders. Changes in odds ratios between leading cause of death pairs do not occur in isolation from other diseases. Our results may serve as a reference point for optimizing strategies for multimorbidity prevention.
Introduction
Timing of death is determined by one’s genetic predisposition to diseases, lifestyle, social environment, and proneness to external adversities [1]. The extension of human life, particularly in Western Europe and North America after World War II, has been driven by significant declines in infant and adult mortality [2], leading to a concentration of deaths in the oldest age groups [3]. However, research consistently shows that extending lifespan often comes with an increase in the number of years lived with disease or disability [4], 5]. As diseases accumulate over a person’s lifetime, it is rarely a single health condition that causes death [6]. In Sweden, 60 % of deaths are attributed to at least two causes [7]; in France, 65 % [8]; in the USA, 80 % [9], comparable to Canada [10] and Australia [11]. In Czechia, nearly 90 % of deaths result from multiple causes [12]. Consequently, the approach of considering only the single underlying cause of death – defined as the condition that initiates the chain of morbid events leading to death – overlooks the majority of health conditions listed on the death certificate, providing only a limited understanding of the lethal disease process and interplay between causes of death in aged societies [13]–22]. Some authors suggest that the timing of death is influenced more by the presence of multiple coexisting diseases than by a single dominant cause that “wins” in the conventional competing risk framework [23]–26]. Understanding how diseases interact is therefore crucial not only for more accurate estimation of mortality risks in multimorbid populations but also for preventing the emergence of such interactions, because multimorbidity is strongly associated with rapid negative changes in health status, including functional decline and increased frailty [27], 28].
Rising prevalence of multiply caused deaths has led to increased interest in pairwise associations between causes of death [29], [30], [31]. However, most of these studies face important limitations. First, they often focus on causes of death associated with selected diseases, for example diabetes [32], [33], [34], Alzheimer’s disease and dementia [35], [36], [37], sepsis [38], [39], [40], [41], or heart diseases [42], 43]. Second, they explore relationships between the underlying cause of death and contributory causes (non-underlying conditions), frequently neglecting the connections solely among contributory causes [6], 44], 45]. However, these non-underlying conditions are often essential components of the lethal process, potentially driving translation of “a disease” into “the underlying cause of death”. Among the contributory conditions, physicians frequently record diabetes, dementia, sepsis, hypertension, and other cardiovascular diseases [9].
Several studies have moved beyond the narrow focus on pairwise associations between causes of death [16], 46], 47]. Egidi et al. [16] address the complexity of relationships between causes of death by applying network analysis, providing an innovative visualization of the complex relationships between major cause of death groups in an intuitively understandable manner. However [16], focus solely on measuring strength of relationships between cause of death groups and the authors do not examine the potential impacts of their changes, which is the focus of the current study. Above that, as highlighted by [30], studies focusing on identifying clusters of causes of death involving more than two causes often lack reliability, as application of different clustering algorithms leads to identification of different clusters [30], 31].
While the dependence between causes of death is hard to be denied, regardless of the research focus and methods applied, to date, no study has explicitly delved into the question of how the architecture of relations between causes of death would change if certain disease pairs that are known to co occur non randomly suddenly become independent. This is particularly important because, for instance, in the USA, the strengths of associations between leading pairs of causes of death have undergone substantial changes since the year 2000 (Figure 3). If there is a change in the association between diseases i and j, how could this affect the relationships between other diseases related to i? Understanding how changes in the relationship between disease i and disease j influence the relationship between disease i and disease k provides insight into the complexity of disease interdependencies and the far-reaching effects of altering associations between just one pair. This might be valuable for the early detection of newly emerging comorbidities, which, consequently, might contribute to both the rapid functional declines and the increased costs of health care, which are associated with treatment of complex multimorbid patterns [48], 49].
To explore the effect of disruptions in associations between diseases, we work with the US multiple cause of death data in 2019 [9] and measure the strength of association between pairs of diseases with odds ratios (OR). Then, we identify the most frequent cause of death (COD) pairs and make them independent by adjusting the marginal distributions of the respective contingency tables. Setting dependent COD to be independent has ripple effects on the associations with the remaining CODs. The primary objective of this study is to investigate the effects of such disruptions introduced into the structure of cause of death dependencies.
Data
The US Multiple Cause-of-Death Mortality Data was obtained from the National Bureau of Economic Research, which compiles microdata on mortality from the National Vital Statistics System of the National Center for Health Statistics (NCHS). Each record in NCHS Mortality Multiple Cause Files corresponds to one death which occurred during a single year in the USA and consists of sociodemographic variables as well as of two types of variables for recording the causes of death. The first type contains “Entity Axis Codes” which are recoded to the second type, “Record Axis Codes”, to eliminate inconsistencies, such as redundant codes, diagnoses incompatible with the sex of the deceased person, dual codes, etc. [50]. In the present paper we use the “Record Axis Codes” to study relations between causes of death. We create all possible combinations of codes recorded on the death certificate, which are coded in accordance with the Shortlist of causes of death provided by the Human Cause-of-Death Database [51]. We introduce the disruptions to leading COD pairs, which accounted for nearly 70 % of deaths in the USA in 2019. The selected pairs are highlighted in blue in Figure 3. The ICD codes included in each leading disease group are listed in Table 1, and the complete classification of diseases is provided in the Supplementary material.
Leading cause of death pairs, USA, 2019, odds ratios and relative share of links with diseases from the same category (self-loops).
Disease 1 | Disease 2 | OR | Number of death | Self-loops in disease 1, % | Self-loops in disease 2, % |
---|---|---|---|---|---|
Heart diseases (I00-I52) | Metabolic diseases (E00-E90) | 3.80 | 376,200 | 0.46 | 0.18 |
Heart diseases (I00-I52) | Respiratory diseases (J30-J98) | 1.24 | 357,178 | 0.46 | 0.22 |
Heart diseases (I00-I52) | Mental disorders (F00-F99) | 1.09 | 339,317 | 0.46 | 0.09 |
Mental disorders (F00-F99) | Respiratory diseases (J30-J98) | 1.99 | 219,423 | 0.09 | 0.22 |
Mental disorders (F00-F99) | Symptoms and signs (R00-R94, R96-R99) | 1.16 | 193,781 | 0.09 | 0.48 |
Heart diseases (I00-I52) | Genitourinary diseases (N00-O99) | 1.31 | 159,136 | 0.46 | 0.10 |
Cerebrovascular diseases (G45, I60-I69) | Heart diseases (I00-I52) | 1.29 | 144,699 | 0.05 | 0.46 |
Mental disorders (F00-F99) | Metabolic diseases (E00-E90) | 1.38 | 139,542 | 0.09 | 0.18 |
Metabolic diseases (E00-E90) | Respiratory diseases (J30-J98) | 1.23 | 130,775 | 0.18 | 0.22 |
-
Source: data: [9]; authors calculations.
In 2019, there is a total of 2,861,523 death records in the USA. Among these records, approximately 80 % were attributed to at least two causes of death. Consequently, of all the medical information recorded on death certificates, the single underlying causes of death accounted for only 30 %. The highest average number of conditions (exceeding 4) was mentioned with diseases of blood and blood-forming organs (D50–D89), diseases of the skin, subcutaneous tissues, musculoskeletal system and connective tissue (L00–M99) as well as with endocrine, nutritional and metabolic disorders (E00–E90). At the other end, neoplasms (C00–D48) are the only diseases, whose average number of additional diagnoses is lower than three.
Table 1 illustrates the most frequent cause-of-death pairs, collectively representing nearly 70 % of all deaths. Notably, among the leading causes of death, there is a recurrent presence of heart diseases (I00–I52), other respiratory diseases (J30–J98), and symptoms and signs (R00–R99, excluding R95), the latter sometimes referred to as ill-defined causes of death. Next, Table 1 shows odds ratios (OR) as well as the percentage of self-loops, which indicate how often a disease is recorded with another disease from the same disease group on the death certificate. These figures illustrate the extent to which cause-of-death pairs are excluded from our analysis, given that we do not investigate relationships within the major cause-of-death groups. Notably, there is considerable variation among causes of death, with the percentage of self-loops ranging from 1 % for acute respiratory diseases to as high as 48 % for symptoms and signs.
It is important to note how we address cases where deaths result from two identical causes. This becomes more common when causes of death are grouped into broader categories, as done in this paper. As recommended, a single death should not be attributed to multiple identical causes. Therefore, after the causes of death were aggregated following Shortlist of COD [51], the duplicities have been excluded from the analysis.
Methodology
Various measures have been proposed to assess the association between diseases, including the odds ratio (OR), relative risk (RR), and conditional probabilities. Specifically for analyzing associations between multiple causes of death, the cause of death association indicator (CDAI) has been developed, which is a standardized measure of the OR. Here, we use the OR for several reasons. Firstly, RR is unsuitable when the true exposure is unknown [52], and since we are working with period data, our exposure is not known. Secondly, conditional probabilities do not account for the number of individuals without the disease (or without a pair), which might introduce additional biases. Thirdly, we do not use CDAI because it can be distorted by the need to calculate age-specific associations. In our study, we include all associations involving diseases in leading cause of death pairs and do not exclude rare disease pairs from the analysis. It can be shown, that OR and CDAI are highly correlated (see Supplementary material).
We quantify the strength of associations between causes of death using odds ratios (OR). The OR are calculated by the formula [53]:
where the D i,j is the number of deaths due to both causes i and j. The negation sign ¬ expresses the absence of cause i or j. For example, D ¬i,¬j is the number of deaths due to neither i, nor j. The odds ratio higher than one indicates significantly increased risk of co-occurrence of causes of death i and j.
We calculate 95 % confidence intervals (CI) for the OR by using normal distribution approximation, as in [54]:
where σ is the standard error of the odds ratio:
The measure of association described above detects non-randomly connected CODs. The significance of these associations is evaluated using the chi-squared (χ 2) test (see [55] for more details). After identifying significant associations among leading cause of death pairs, we optimize the marginal distributions of the corresponding contingency tables, ensuring that the χ2 test statistic suggests independence between the causes of death in each pair. The process of optimizing the χ 2 test statistic for two factors is illustrated in Figure 1.
![Figure 1:
The process of adjusting the results of χ
2to achieve independence between diseases, example of heart disease and metabolic diseases. Source: data: [9]; authors calculations. X
2=test statistic for each cell of 2-way table; sum X
2=total test statistic; constrain: enforced on the total number of deaths, ensuring that the death counts in the optimal solution always sum to the total population death count. Note: Starting with the original distribution of deaths within the contingency table highlighted in green, we can perform the chi-squared (χ
2) test to measure the association between two factors (Table “Former χ
2 Test” on Figure 1). In this illustrative example, the resulting p-value is lower than 0.05, leading to the conclusion that the null hypothesis of independence between the factors can be rejected. The corresponding odds ratio (OR) is 3.8010. Next, we optimize the marginal distributions of the original contingency table (Table “χ
2 Test Adjusted for Independence” on Figure 1) to search for p-values that indicate independence (p-value >0.05). This process is iteratively applied to varying D
i
and D
j
and the results of the χ2 Test are recorded after each iteration. The sequences of D
i
(and similarly D
j
) begin at 0, assuming no deaths occur with cause i (or j), and progress to the total number of deaths, assuming all deaths are attributed to cause i (or j). Each step in the sequence increments by 0.1 D
i,j
.](/document/doi/10.1515/em-2024-0033/asset/graphic/j_em-2024-0033_fig_001.jpg)
The process of adjusting the results of χ 2to achieve independence between diseases, example of heart disease and metabolic diseases. Source: data: [9]; authors calculations. X 2=test statistic for each cell of 2-way table; sum X 2=total test statistic; constrain: enforced on the total number of deaths, ensuring that the death counts in the optimal solution always sum to the total population death count. Note: Starting with the original distribution of deaths within the contingency table highlighted in green, we can perform the chi-squared (χ 2) test to measure the association between two factors (Table “Former χ 2 Test” on Figure 1). In this illustrative example, the resulting p-value is lower than 0.05, leading to the conclusion that the null hypothesis of independence between the factors can be rejected. The corresponding odds ratio (OR) is 3.8010. Next, we optimize the marginal distributions of the original contingency table (Table “χ 2 Test Adjusted for Independence” on Figure 1) to search for p-values that indicate independence (p-value >0.05). This process is iteratively applied to varying D i and D j and the results of the χ2 Test are recorded after each iteration. The sequences of D i (and similarly D j ) begin at 0, assuming no deaths occur with cause i (or j), and progress to the total number of deaths, assuming all deaths are attributed to cause i (or j). Each step in the sequence increments by 0.1 D i,j .
The key purpose of this approach is to explore how the disruption of significant associations between leading causes of death might impact associations with their neighboring diseases. Therefore, the process involves adjustments to the marginal distributions of the contingency tables. To initiate this optimization, we first assume the number of deaths involving both causes i and j (D i,j ) to be fixed. Then, we calculate the χ 2 statistic while varying the sequences of the number of deaths due to cause i (D i ) and the number of deaths due to cause j (D j ). These sequences begin at D i,j , signifying the assumption that all individuals who died due to at least one of the diseases i or j also died due to the other disease from the pair i, j. The sequences conclude at N, representing the total number of deaths within the population. By employing this upper bound, we assume that all deaths are attributed exclusively to either disease i or disease j. In addition, we impose a natural constraint that the sum of D i and D ¬i,j should be less than N. To examine all resulting pairs of values for D i and D j , we implement a loop for the sequences specified above. Note that we do not test for independence with each potential number of deaths within these sequences individually, as it would be highly time-consuming. Instead, we set the intervals (increments) for the loops to be equal to 10 % of D i,j.
Using the sequences of varying D i and D j , while keeping D i,j at its original value, we recompute the remaining elements in the contingency tables. Then, we conduct χ 2 tests and extract all cases that indicate independence at a confidence level of 99 %. We will refer to this selection as “independence scenarios.” As shown in Figure 2, for each pair of leading causes of death, the marginal distribution combinations that indicate independence tend to cluster around the yellow line. This line exhibits a characteristic shape of 1/x -hyperbola (Figure 2).
![Figure 2:
Independence scenarios between causes of death, USA, 2019. Source: data: [9]; authors calculations. Both axes plot number of deaths from causes marked on the axes. Units on both axis are in 106 (for instance, 1=1 000 000 deaths); black dot: original combination of D
i
and D
j
; red dot: independence scenario applied here.](/document/doi/10.1515/em-2024-0033/asset/graphic/j_em-2024-0033_fig_002.jpg)
Independence scenarios between causes of death, USA, 2019. Source: data: [9]; authors calculations. Both axes plot number of deaths from causes marked on the axes. Units on both axis are in 106 (for instance, 1=1 000 000 deaths); black dot: original combination of D i and D j ; red dot: independence scenario applied here.
In the next step, we integrate the “independence scenarios” into the cause-of-death structure. We take each adjusted marginal distribution for causes i and j and implement it in order to calculate adjusted OR for all cause of death pairs that include either disease i or disease j. These OR represent the associations between diseases i and k (or j and k) that would exist if diseases i and j were independent. Here, k stands for all other causes of death under consideration, excluding causes i and j, respectively.
As a result, for each pair of causes of death, we obtain a distribution of adjusted OR, each corresponding to a different optimization solution or, in other words, an independence scenario. The next step is to determine what “independence scenario” to consider for studying the influence of the inserted independence on the other cause-of-death associations. We select the “independence scenario” corresponding to the relocation of the minimum number of deaths in the contingency table. The rationale behind this criterion is that it could be considered the one closest to reality as reaching independence requires minimal distortions in the distribution of deaths. In Figure 2, we depict two dots; the coordinates correspond to the original values of D i and D j (black dots) and their modification according to “minimum relocation scenario” (red dots). In summary, the red dots represent the solution that is further interpreted, and the distance between the dots signifies how much change is needed to dissolve the association between leading cause-of-death pairs.
The analysis was performed in R Studio version 4.3.1 and the preprocessing of raw NCHS data was done in SAS version 9.4.
Findings
Figure 3 shows the odds ratio (OR) between cause of death groups, with higher values indicating stronger associations. The leading cause of death pairs are highlighted in blue, where we also apply the distortions.
![Figure 3:
Odds ratios between major cause-of-death groups, USA, 2019 (left) and index of odds ratios (base=2000), leading cause of death pairs, USA, 2000–2019 (right). Source: data: [9]; authors calculations.](/document/doi/10.1515/em-2024-0033/asset/graphic/j_em-2024-0033_fig_003.jpg)
Odds ratios between major cause-of-death groups, USA, 2019 (left) and index of odds ratios (base=2000), leading cause of death pairs, USA, 2000–2019 (right). Source: data: [9]; authors calculations.
Tables 2a and 2b summarize the effects of the dissolution of leading disease pairs containing diseases i and j on the association between i and k (or j and k), where k represents all other diseases except those involved in the pair (i, j) that undergoes dissolution. As mentioned earlier, these tables illustrate the effect under the minimum relocation scenario. Certain disease pairs exhibit only mild associations, requiring minimal distortion to render them independent. Examples include the association of mental and behavioral disorders with ill-defined causes of death, as well as heart diseases paired with other respiratory diseases or diseases of the genitourinary system.
Impacts of distortions of associations between causes of death i and j on disease i (in the column heading).
Cause of death pair (i, j) being dissolved (minimum relocation scenario) | ||||||||||
Metabolic + other respiratory | Mental + other respiratory | Mental + symptoms | Mental + metabolic | Heart + other respiratory | Heart + genitourinary | Heart + metabolic | Heart + mental | Cerebrovascular + heart | ||
Neighboring disease of i | Infectious | 1.15 (0.88) | 0.67 (0.96) | 0.64 (0.92) | 0.64 (0.92) | 0.70 (1.00) | 0.70 (0.99) | 0.70 (1.00) | 1.42 (2.03) | 0.51 (0.88) |
Neoplasms | 0.50 (0.87) | 0.78 (0.95) | 0.74 (0.91) | 0.74 (0.91) | 0.30 (1.00) | 0.30 (0.99) | 0.30 (1.00) | 0.69 (2.30) | 0.26 (0.88) | |
Diseases of blood | 2.08 (0.88) | 0.91 (0.96) | 0.88 (0.92) | 0.88 (0.92) | 1.45 (1.00) | 1.44 (0.99) | 1.45 (1.00) | 2.82 (1.95) | 0.93 (0.88) | |
Metabolic | () | 1.31 (0.95) | 1.25 (0.91) | () | 3.80 (1.00) | 3.78 (0.99) | () | 8.81 (2.32) | 1.12 (0.86) | |
Mental | 1.18 (0.85) | () | () | () | 1.09 (1.00) | 1.08 (0.99) | 1.09 (1.00) | () | 0.90 (0.86) | |
Nervous | 1.05 (0.87) | 0.65 (0.95) | 0.63 (0.92) | 0.63 (0.92) | 0.74 (1.00) | 0.74 (0.99) | 0.74 (1.00) | 1.55 (2.09) | 0.96 (0.87) | |
Heart | 2.60 (0.68) | 1.00 (0.92) | 0.93 (0.86) | 0.93 (0.86) | () | () | () | () | () | |
Cerebrovascular | 1.15 (0.88) | 1.00 (0.95) | 0.96 (0.92) | 0.96 (0.92) | 1.29 (1.00) | 1.28 (0.99) | 1.29 (1.00) | 2.64 (2.05) | () | |
Other circulatory | 1.58 (0.88) | 1.23 (0.96) | 1.19 (0.92) | 1.19 (0.92) | 2.18 (1.00) | 2.17 (0.99) | 2.18 (1.00) | 4.30 (1.97) | 1.31 (0.88) | |
Acute resp. | 0.87 (0.88) | 0.8 (0.96) | 0.78 (0.92) | 0.78 (0.92) | 0.79 (1.00) | 0.79 (0.99) | 0.79 (1.00) | 1.56 (1.97) | 0.62 (0.88) | |
Other resp. | () | () | 1.79 (0.90) | 1.79 (0.90) | () | 1.23 (0.99) | 1.24 (1.00) | 2.96 (2.38) | 0.68 (0.86) | |
Digestive | 1.22 (0.88) | 0.72 (0.96) | 0.70 (0.92) | 0.70 (0.92) | 0.71 (1.00) | 0.71 (0.99) | 0.71 (1.00) | 1.44 (2.02) | 0.42 (0.88) | |
Diseases of skin | 2.37 (0.88) | 1.27 (0.96) | 1.22 (0.92) | 1.22 (0.92) | 1.47 (1.00) | 1.47 (0.99) | 1.47 (1.00) | 2.87 (1.94) | 0.91 (0.88) | |
Genitourinary | 1.27 (0.88) | 0.74 (0.95) | 0.72 (0.92) | 0.72 (0.92) | 1.32 (1.00) | () | 1.32 (1.00) | 2.72 (2.06) | 0.63 (0.88) | |
Perinatal | 0.36 (0.89) | 0.20 (0.96) | 0.19 (0.93) | 0.19 (0.93) | 0.27 (1.00) | 0.27 (0.99) | 0.27 (1.00) | 0.52 (1.91) | 0.38 (0.89) | |
Symptoms | 0.82 (0.85) | 1.10 (0.94) | () | 1.05 (0.90) | 0.64 (1.00) | 0.64 (0.99) | 0.64 (1.00) | 1.57 (2.43) | 0.66 (0.86) |
Impacts of distortions of associations between causes of death i and j on disease j (in the column heading).
Cause of death pair (i, j) being dissolved (minimum relocation scenario) | ||||||||||
Metabolic + other respiratory | Mental + other respiratory | Mental + symptoms | Mental + metabolic | Heart + other respiratory | Heart + genitourinary | Heart + metabolic | Heart + mental | Cerebrovascular + heart | ||
Neighboring disease of j | Infectious | 1.78 (0.96) | 1.11 (0.96) | 1.11 (0.96) | 1.08 (0.96) | 1.65 (0.96) | 4.04 (0.96) | 0.73 (0.96) | 0.38 (0.96) | 0.70 (0.96) |
Neoplasms | 0.69 (0.95) | 0.41 (0.56) | 0.36 (0.96) | 0.47 (0.82) | 0.64 (0.88) | 0.53 (0.86) | 0.31 (0.53) | 0.40 (0.49) | 0.30 (0.99) | |
Diseases of blood | 1.50 (0.96) | 0.97 (0.62) | 1.55 (0.97) | 1.98 (0.84) | 1.41 (0.90) | 2.82 (0.87) | 1.36 (0.58) | 0.54 (0.56) | 1.44 (0.99) | |
Metabolic | () | 0.70 (0.57) | 0.92 (0.96) | () | 1.08 (0.88) | 1.23 (0.85) | () | 0.70 (0.51) | 3.77 (0.99) | |
Mental | 1.89 (0.95) | () | () | () | 1.73 (0.86) | 0.66 (0.85) | 0.70 (0.51) | () | 1.08 (0.99) | |
Nervous | 0.84 (0.96) | 0.52 (0.60) | 0.92 (0.96) | 0.99 (0.82) | 0.78 (0.89) | 0.76 (0.87) | 0.66 (0.55) | 0.37 (0.54) | 0.74 (0.99) | |
Heart | 1.15 (0.92) | 0.51 (0.41) | 0.61 (0.94) | 2.26 (0.59) | () | () | () | () | () | |
Cerebrovascular | 0.76 (0.96) | 0.48 (0.61) | 0.74 (0.96) | 1.08 (0.83) | 0.71 (0.89) | 0.63 (0.87) | 0.73 (0.56) | 0.57 (0.54) | () | |
Other circulatory | 0.99 (0.96) | 0.64 (0.62) | 1.07 (0.97) | 1.50 (0.84) | 0.93 (0.90) | 1.54 (0.87) | 1.03 (0.58) | 0.72 (0.56) | 2.17 (0.99) | |
Acute resp. | 2.37 (0.96) | 1.51 (0.61) | 0.96 (0.97) | 0.82 (0.84) | 2.21 (0.89) | 1.86 (0.87) | 0.57 (0.58) | 0.47 (0.56) | 0.79 (0.99) | |
Other resp. | () | () | 0.94 (0.96) | 0.98 (0.80) | () | 1.29 (0.84) | 0.63 (0.51) | 0.93 (0.47) | 1.23 (0.99) | |
Digestive | 1.02 (0.96) | 0.65 (0.61) | 1.14 (0.96) | 1.15 (0.83) | 0.95 (0.89) | 2.03 (0.86) | 0.78 (0.56) | 0.42 (0.55) | 0.71 (0.99) | |
Diseases of skin | 1.30 (0.96) | 0.84 (0.62) | 1.54 (0.97) | 2.25 (0.84) | 1.22 (0.90) | 1.88 (0.87) | 1.55 (0.58) | 0.74 (0.56) | 1.47 (0.99) | |
Genitourinary | 1.48 (0.96) | 0.92 (0.60) | 1.09 (0.96) | 1.20 (0.83) | 1.37 (0.89) | () | 0.81 (0.56) | 0.42 (0.54) | 1.31 (0.99) | |
Perinatal | 0.49 (0.96) | 0.32 (0.63) | 0.66 (0.97) | 0.35 (0.85) | 0.46 (0.90) | 0.60 (0.88) | 0.24 (0.59) | 0.12 (0.57) | 0.27 (0.99) | |
Symptoms | 0.93 (0.95) | 0.53 (0.54) | () | 0.77 (0.80) | 0.85 (0.87) | 0.95 (0.84) | 0.49 (0.50) | 0.55 (0.47) | 0.64 (0.99) |
-
Source: data: [9]; authors calculations. Note: The table shows adjusted OR and the ratio between the original and adjusted OR in brackets. A value below 1 in brackets indicates that, assuming independence between the diseases listed in the column headings, the association between the disease in the row and the first disease in the pair (in Table 2a) or the second disease in the pair (in Table 2b) would also decrease.
Table 2a shows the adjusted OR between diseases in rows and the first diseases in the pairs, that are made independent. These pairs are in the column headings. Table 2b presents the same information but in relation to the second disease in the column headings. In both tables, adjusted OR that significantly differ from the original values are highlighted in pink. Additionally, in brackets, we provide the ratio between the adjusted and original OR. For example, if the adjusted odds ratio between infectious diseases and metabolic disorders is 1.15, the figure 0.88 indicates a 12 % decrease in the association between infectious and metabolic diseases if metabolic diseases and other respiratory disorders were independent.
Disrupting associations between leading cause of death pairs would lead to substantial changes in the architecture of cause of death relations. In most cases, the associations would decrease. However, disrupting the association between heart diseases and mental disorders would increase the odds ratios with heart diseases and all other cause-of-death groups except for mental disorders. It is noteworthy that achieving independence even under the minimum relocation scenario requires substantial distortions in the marginal distribution of deaths to make heart diseases and mental disorders independent (Figure 2, Panel A).
However, the diseases exhibit varying degrees of decrease in their associations. The most pronounced decreases are observed in pairs of mental and other respiratory diseases (Figure 2, Panel G), heart and metabolic diseases (Figure 2, Panel B), or heart and mental diseases (Figure 2, Panel A). The specific role of mental and metabolic diseases in the structure of disease interrelations has been previously identified [56], [57], [58]. These diseases are referred to as bridging diseases, indicating that they do not belong to any specific cluster of diseases but rather mediate relationships between seemingly unrelated diseases. The widespread impact of distortions involving mental and metabolic diseases might reflect their unique position within the architecture of disease dependencies.
Furthermore, there are several disease pairs for which the effect of disruption would lead to the same outcome as for pair being disrupted, resulting in their independence as well. This applies to associations such as mental with heart and mental with cerebrovascular diseases if mental and other respiratory diseases are disrupted. A similar effect would occur with the disruption of metabolic and other respiratory diseases on nervous and metabolic diseases, or on digestive and respiratory diseases. This effect might again point to transitive nature of relations involving mental and metabolic diseases, where making them independent of disease i also yields independence from disease k.
Lastly, the impact of disruption of cerebrovascular and heart diseases is quite specific, as introducing their hypothetical independence would not affect relations between heart diseases and other major disease groups (Table 2b, last column). Similarly, assuming independence between heart diseases and respiratory or metabolic disorders would not substantially alter the overall structure of relationships involving heart diseases (Table 2a, column Heart diseases + Other respiratory diseases).
Discussion
In this paper, we quantify the strength of associations between pairs of major CODs in the USA in 2019. We introduce disruptions into the respective contingency tables while searching for marginal distributions that reflect independence between the two causes. We propose different “independence scenarios” for each of the most frequent COD pairs and incorporate in the structure of cause-of-death dependencies the scenario corresponding to relocating the minimum number of deaths in the respective contingency table. In this setting, we examine the effect of this dissolution on associations of other pairs of diseases.
Our results indicate significant changes, mostly decreases, in the strength of association between diseases i and k (or j and k). The most pronounced effects would be observed (i) on mental and behavioral disorders if these would be independent on heart diseases, next (ii) on endocrine, nutritional and metabolic diseases if these would be independent on heart diseases and (iii) on other respiratory diseases if no dependence would exist between them and mental disorders. On the other hand, the dissolution of the association of heart diseases with mental and behavioral disorders leads to increased association of the former with all other causes, especially with neoplasms and endocrine and metabolic diseases. We identified pairs, in which achieving independence in one pair would imply independence in another. For instance, independence between mental and other respiratory diseases would lead to independence between mental and cerebrovascular as well as with mental and heart.
The outcomes are to some extent predictable. The most notable change occurs when the imposed independence is far from reality. Some of our findings are less intuitive, as for example, the ones for pairs involving heart diseases and other respiratory diseases, genitourinary diseases, and endocrine, nutritional and metabolic conditions. Even if the total amount of relocation for these pairs is comparable to (or greater than) pairs such as endocrine, nutritional metabolic diseases with other respiratory diseases or mental and behavioral disorders with ill-defined conditions, the dissolution does not have a significant effect on the associations with other diseases. Thus, the results are not predictable based on distinct D i,j .
Our results showed that the dissolution of heart diseases and mental diseases could increase the association between heart diseases and almost all other disease groups. While there is a large body of literature discussing the links between heart and mental diseases, to our knowledge, no medical explanation exists about how changes in this link affect other diseases. For this analysis, we propose the following explanation: Deaths with mental diseases are usually associated with oldest-old ages. Therefore, dying with mental disease, might be interpreted as a condition for long lifespan. If this condition is cancelled, we might see increased associations between heart diseases and other causes of death, simply because some individuals would die sooner, where the associations between heart and other diseases is much more common.
Next, we observed a significant weakening of connections when disrupting associations related to endocrine, nutritional, and metabolic diseases. For example, such disruptions affected connections with respiratory diseases or mental and behavioral disorders. Previous studies have demonstrated that endocrine, nutritional and metabolic diseases develop more widespread connections with other diseases compared to other major disease groups that tend to cluster within their respective organ systems. Our analysis has revealed that connections with these diseases might exhibit a high degree of transitivity. This is due to their heightened sensitivity to disruptions in one connection, significantly impacting other connections with endocrine and metabolic diseases.
In other words, the independence of pairs with mental and metabolic diseases, which leads to a decrease in associations with other diseases, might reflect the fact that these frequently co-occurring chronic conditions “open the doors” for developing complex multimorbid patterns. However, further analysis is needed to determine if increasing the dependence in pairs with metabolic and mental diseases would have a similar effect on the dependence between mental, metabolic, and other diseases.
We also identified dependencies that primarily exist in pairwise associations, meaning that disrupting their association does not affect relationships with other diseases. This was particularly evident in the case of leading pairs involving heart diseases.
Our study has several limitations. First, we only allow the relocation of deaths to have an impact on the nodes that are direct neighbors of the disease pairs whose associations are disrupted. However, in reality the relocation of deaths can potentially influence the associations between other diseases as well. For example, changes in the association between heart and cerebrovascular diseases could potentially impact associations between other circulatory and blood diseases (as other circulatory diseases are frequently associated with both heart and cerebrovascular), as well as other disease pairs not directly involving either heart or cerebrovascular diseases. Second, we use only odds ratios, even though there are more sophisticated measures for the analysis of cause-of-death relations, such as the cause-of-death association indicator [6]. This measure is standardized for different distributions of deaths by age and cause. However, we do not use it because it is extremely time-consuming to calculate it for all possible combinations of D i and D j . Computation time increases dramatically if the age dimension, required to calculate cause-of-death association indicators, is added to the calculation process. Nevertheless, age certainly must play an important role, and further research is needed to evaluate how the results change if we relocate deaths occurring only in selected age groups. Third, there are limitations in the artificial approach to searching for independence between diseases. In the present paper, we were searching for an optimum by testing sequences of D i and D j . However, independence in contingency tables might be achieved in other ways, too. Lastly, we need to acknowledge the limitations that stem from the data we use. Multiple cause-of-death datasets are notorious for their lack of international comparability. Therefore, we should incorporate data from other countries into our future analyses. Last, the current findings do not explore in detail the specific interventions made in the contingency tables – that is, which deaths are being relocated in the minimal relocation scenario. This naturally limits the ability to derive practical implications from the findings. Future research could address this by focusing on only selected disease pairs and investigating in greater detail the optimal strategies for reducing their dependence.
Conclusions
In conclusion, studying pairwise associations between diseases without considering the complexity of cause-of-death interrelations might produce an incomplete picture of the overall COD structure. This study attempts to show that distortions introduced in the cause-of-death structure have an impact beyond the diseases under study. Changes in odds ratios between leading cause of death pairs do not happen in isolation from other diseases.
Our results can provide valuable insights for optimizing strategies aimed at preventing multimorbidity, which is recognized as one of the most significant challenges for healthcare systems in developed societies due to the complexity of treating multiple health conditions simultaneously [59]. Further steps in unveiling the robustness of the COD architecture, which are out of the scope of this paper, include incorporating the age dimension in the analysis, as well as studying the effect of introducing the reverse: adding statistically significant associations where they are not present or strengthening weak associations.
Funding source: SCOR Foundation for Science through the funding for the “SCOR Chair in Mortality Research"
Acknowledgments
EU thanks to Trifon I. Missing for helping with drafting the first version of the manuscript.
-
Research ethics: Not applicable.
-
Informed consent: Not applicable.
-
Author contributions: The author has accepted responsibility for the entire content of this manuscript and approved its submission.
-
Use of Large Language Models, AI and Machine Learning Tools: LLM were used for language editing.
-
Conflict of interest: The author states no conflict of interest.
-
Research funding: The research was supported by the SCOR Foundation for Science through the funding for the “SCOR Chair in Mortality Research”.
-
Data availability: The Data on multiple causes of death for the USA are available at https://catalog.data.gov/dataset/cdc-wonder-mortality-multiple-cause-of-death.
References
1. Caselli, G, Vallin, J, Wunsch, G, editors. Demography: analysis and synthesis: a treatise in population studies. Amsterdam: Academic Press; 2006, 4 vols.Search in Google Scholar
2. Cutler, D, Deaton, A, Lleras-Muney, A. The determinants of mortality. J Econ Perspect 2006;20:97–120. https://doi.org/10.1257/jep.20.3.97.Search in Google Scholar
3. Nusselder, WJ, Mackenbach, JP. Rectangularization of the survival curve in The Netherlands, 1950–1992. Gerontologist 1996;36:773–82.https://doi.org/10.1093/geront/36.6.773.Search in Google Scholar PubMed
4. Carapetis, JR, Dadi, AF, Abate, KH, Abbafati, C, Abbas, KM, Abd-Allah, F, et al.. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1211–59. https://doi.org/10.1016/s0140-6736(17)32154-2.Search in Google Scholar PubMed PubMed Central
5. Salvatore, F. The shift of the paradigm between ageing and diseases. Clin Chem Lab Med 2020;58:1635–44. https://doi.org/10.1515/cclm-2020-0125.Search in Google Scholar PubMed
6. Désesquelles, AF, Salvatore, MA, Pappagallo, M, Frova, L, Pace, M, Meslé, F, et al.. Analysing multiple causes of death: which methods for which data? An application to the cancer-related mortality in France and Italy. Eur J PopRevue Eur De Demograp 2012;28:467–98. https://doi.org/10.1007/s10680-012-9272-3.Search in Google Scholar
7. Janssen, JMJ. Di Lucca, M, Ziegler, B. Statistics on multiple causes of Death. The National Board of Health and Welfare. 2023. Available: https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/statistik/2023-5-8523.pdf.Search in Google Scholar
8. Désesquelles, A, Meslé, F. A comparison of French and US old-age mortality patterns using multiple cause-of-death data. In: IUSSP general population conference; 2001. Available: https://iussp.org/sites/default/files/Brazil2001/s10/S15_01_desesquelles.pdf.Search in Google Scholar
9. NCHS. 2019. Multiple mortality public use data. Available: https://www.cdc.gov/nchs/nvss/mortality_public_use_data.htm.Search in Google Scholar
10. Willkins, K, Wysocki, M, Morin, C, Wood, P. Multiple causes of death. Statistique Canada. 1997. Available: https://www150.statcan.gc.ca/n1/en/pub/82-003-x/1997002/article/3235-eng.pdf?st=-a2knS4h.Search in Google Scholar
11. Australian Institute of Health and Welfare. Multiple causes of death. In: Bulletin no. 105. Cat. no. AUS 159. Canberra: AIHW; 2012.Search in Google Scholar
12. Czech Statistical Office. Deaths by cause of death, sex and age; 2022. https://www.czso.cz/csu/czso/priciny-umrti.Search in Google Scholar
13. Adair, T, Lopez, AD. The role of overweight and obesity in adverse cardiovascular disease mortality trends: an analysis of multiple cause of death data from Australia and the USA. BMC Med 2020;18:199. https://doi.org/10.1186/s12916-020-01666-y.Search in Google Scholar PubMed PubMed Central
14. Barbieri, M, Désesquelles, A, Egidi, V, Demuru, E, Frova, L, Meslé, F, et al.. Obesity-related mortality in France, Italy, and the United States: a comparison using multiple cause-of-death analysis. Int J Publ Health 2017;62:623–9. https://doi.org/10.1007/s00038-017-0978-1.Search in Google Scholar PubMed PubMed Central
15. Désesquelles, A, Salvatore, MA, Frova, L, Pace, M, Pappagallo, M, Meslé, F, et al.. Revisiting the mortality of France and Italy with the multiple-cause-of-death approach. Demogr Res 2010;23:771–806. https://doi.org/10.4054/DemRes.2010.23.28.Search in Google Scholar
16. Egidi, V, Salvatore, MA, Rivellini, G, D’Angelo, S. A network approach to studying cause-of-death interrelations. Demogr Res 2018;38:373–400. https://doi.org/10.4054/demres.2018.38.16.Search in Google Scholar
17. Fihel, A, S Trias Llimós, M Muszyńska-Spielauer, M Majerová. Alcohol-related mortality in four European countries: a multiple-cause-of-death study. Drug Alcohol Rev 2023;42:938–45. https://doi.org/10.1111/dar.13624.Search in Google Scholar PubMed
18. Frova, L, Salvatore, MA, Pappagallo, Egidi, V. The Multiple cause of death approach to analyse mortality patterns, Genus 2009:65;1–21.Search in Google Scholar
19. Grippo, F, Désesquelles, A, Pappagallo, M, Frova, L, Egidi, V, Meslé, F. Multi-morbidity and frailty at death: a new classification of death records for an ageing world death. Population studies. 2020. Available online: https://www.tandfonline.com/eprint/S4GD6XKXVJHB3MFMHMV4/full?target=10.1080/00324728.2020.1820558.10.1080/00324728.2020.1820558Search in Google Scholar PubMed
20. Moreno-Betancur, M, Sadaoui, H, Piffaretti, C, Rey, G. Survival analysis with multiple causes of death. Epidemiology 2017;28:12–19. https://doi.org/10.1097/EDE.0000000000000531.Search in Google Scholar PubMed
21. Piffaretti, C, Moreno-Betancur, M, Lamarche-Vadel, A, Rey, G. Quantifying cause-related mortality by weighting multiple causes of death. Bull World Health Organ 2016;94:870–9B. https://doi.org/10.2471/blt.16.172189.Search in Google Scholar PubMed PubMed Central
22. Trias-Llimós, S, Spijker, J. Educational differences in alcohol-related mortality and their impact on life expectancy and lifespan variation in Spain (2016–2018): a cross-sectional analysis using multiple causes of death. BMJ Open 2022;0:e053205. https://doi.org/10.1136/bmjopen-2021-053205.Search in Google Scholar PubMed PubMed Central
23. Mackenbach, JP, Kunst, AE, Lautenbach, H, Oei, YB, Bijlsma, F. Competing causes of death: a death certificate study. J Clin Epidemiol 1997;50:1069–77. https://doi.org/10.1016/s0895-4356(97)00165-0.Search in Google Scholar PubMed
24. Rothman, KJ, Greenland, S. Causation and causal inference in epidemiology. Am J Publ Health 2005;95:S144–50. https://doi.org/10.2105/ajph.2004.059204.Search in Google Scholar
25. Wensink, M, Westendorp, RG, Baudisch, A. The causal pie model: an epidemiological method applied to evolutionary biology and ecology. Ecol Evol 2014;4:1924–30. https://doi.org/10.1002/ece3.1074.Search in Google Scholar PubMed PubMed Central
26. Manton, KG, Tolley, HD, Poss, SS. Life table techniques for multiple-cause mortality. Demography 1976;13:541–64.10.2307/2060509Search in Google Scholar
27. Vetrano, DL, Palmer, K, Marengoni, A, Marzetti, E, Lattanzio, F, Roller-Wirnsberger, R, et al.. Frailty and multimorbidity: a systematic review and meta-analysis. J Gerontol: Series A 2019;74:659–66. https://doi.org/10.1093/gerona/gly110.Search in Google Scholar PubMed
28. Rockwood, K, Mitnitski, A. Frailty in relation to the accumulation of deficits. J Gerontol Ser A: Biol Sci Med Sci 2007;62:722–7. https://doi.org/10.1093/gerona/62.7.722.Search in Google Scholar PubMed
29. Cesari, M, Pérez-Zepeda, MU, Marzetti, E. Frailty and multimorbidity: different ways of thinking about geriatrics. J Am Med Dir Assoc 2017;18:361–4. https://doi.org/10.1016/j.jamda.2016.12.086.Search in Google Scholar PubMed
30. Bishop, K, Balogun, S, Eynstone-Hinkins, J, Moran, L, Martin, M, Banks, E, et al.. Analysis of multiple causes of death: a review of methods and practices. Epidemiology 2023;34:333–44. https://doi.org/10.1097/EDE.0000000000001597.Search in Google Scholar PubMed PubMed Central
31. Lopez-Barrios, M, Peters, P, Klym, M. Definitions and methods for analysis of multiple cause of death: a scoping review. 2023. Available: https://carleton.ca/determinants/wp-content/uploads/SDHL-Methods-Scoping-Review.pdf.10.22215/rrep/2023.sdhl.106Search in Google Scholar
32. Fedeli, U, Zoppini, G, Goldoni, CA, Avossa, F, Mastrangelo, G, Saugo, M. Multiple causes of death analysis of chronic diseases: the example of diabetes. Popul Health Metr 2015;13:1–10. https://doi.org/10.1186/s12963-015-0056-y.Search in Google Scholar PubMed PubMed Central
33. Park, J, Peters, PA. Mortality from diabetes mellitus, 2004 to 2008: a multiple-cause-of-death analysis. Health Rep 2014;25.Search in Google Scholar
34. Romon, I, Jougla, E, Balkau, B, Fagot-Campagna, A. The burden of diabetes-related mortality in France in 2002: an analysis using both underlying and multiple causes of death. Eur J Epidemiol 2008;23:327–34. https://doi.org/10.1007/s10654-008-9235-5.Search in Google Scholar PubMed
35. Adair, T, Temple, J, Anstey, KJ, Lopez, AD. Is the rise in reported dementia mortality real? Analysis of multiple-cause-of-death data for Australia and the United States. Am J Epidemiol 2022;191:1270–9. https://doi.org/10.1093/aje/kwac047.Search in Google Scholar PubMed PubMed Central
36. Désesquelles, A, Demuru, E, Salvatore, MA, Pappagallo, M, Frova, L, Meslé, F, et al.. Mortality from Alzheimer’s disease, Parkinson’s disease, and dementias in France and Italy: a comparison using the multiple cause-of-death approach. J Aging Health 2014;26:283–315. https://doi.org/10.1177/0898264313514443.Search in Google Scholar PubMed
37. Wilkins, K, Parsons, GF, Gentleman, JF, Forbes, WF. Deaths due to dementia: an analysis of multiple-cause-of-death data. Chron Dis Can 1999;20:26–35.Search in Google Scholar
38. Fedeli, U, Piccinni, P, Schievano, E, Saugo, M, Pellizzer, G. Growing burden of sepsis-related mortality in northeastern Italy: a multiple causes of death analysis. BMC Infect Dis 2016;16:1–6. https://doi.org/10.1186/s12879-016-1664-2.Search in Google Scholar PubMed PubMed Central
39. McPherson, D, Griffiths, C, Williams, M, Baker, A, Klodawski, E, Jacobson, B, et al.. Sepsis-associated mortality in England: an analysis of multiple cause of death data from 2001 to 2010. BMJ open 2013;3:e002586. https://doi.org/10.1136/bmjopen-2013-002586.Search in Google Scholar PubMed PubMed Central
40. Melamed, A, Sorvillo, FJ. The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data. Crit Care 2009;13:1–8. https://doi.org/10.1186/cc7733.Search in Google Scholar PubMed PubMed Central
41. Pechholdová, M. Sepsis-related mortality in the Czech Republic: multiple causes of death analysis. Epidemiol Mikrobiol Imunol 2017;66:73–9.Search in Google Scholar
42. Quinones, A, Lobach, I, Maduro, GAJr, Smilowitz, NR, Reynolds, HR. Diabetes and ischemic heart disease death in people age 25–54: a multiple‐cause‐of‐death analysis based on over 400 000 deaths from 1990 to 2008 in New York City. Clin Cardiol 2015;38:114–20. https://doi.org/10.1002/clc.22367.Search in Google Scholar PubMed PubMed Central
43. Rahimi, K, Duncan, M, Pitcher, A, Emdin, CA, Goldacre, MJ. Mortality from heart failure, acute myocardial infarction and other ischaemic heart disease in England and Oxford: a trend study of multiple-cause-coded death certification. J Epidemiol Community Health 2015;69:1000–5. https://doi.org/10.1136/jech-2015-205689.Search in Google Scholar PubMed PubMed Central
44. Redelings, MD, Wise, M, Sorvillo, F. Using multiple cause-of-death data to investigate associations and causality between conditions listed on the death certificate. Am J Epidemiol 2007;166:104. https://doi.org/10.1093/aje/kwm037.Search in Google Scholar PubMed
45. Turner, C, Chandrakumar, D, Rowe, C, Santos, GM, Riley, ED, Coffin, PO. Cross-sectional cause of death comparisons for stimulant and opioid mortality in San Francisco, 2005-2015. Drug Alcohol Depend 2018;185:305–12. https://doi.org/10.1016/j.drugalcdep.2017.12.030.Search in Google Scholar PubMed PubMed Central
46. Hassanzadeh, HR, Sha, Y, Wang, MD. DeepDeath: learning to predict the underlying cause of death with big data. In: 2017 39th Annual international conference of the IEEE Engineering in Medicine and Biology Society. IEEE; 2017:3373–6 pp.10.1109/EMBC.2017.8037579Search in Google Scholar PubMed PubMed Central
47. Jiang, H, Wu, H, Wang, MD. Causes of death in the United States, 1999 to 2014. In: 2017 IEEE EMBS international conference on Biomedical and Health Informatics (BHI). IEEE; 2017:177–80 pp.10.1109/BHI.2017.7897234Search in Google Scholar
48. Moffat, K, Mercer, SW. Challenges of managing people with multimorbidity in today’s healthcare systems. BMC Fam Pract 2015;16:1–3. https://doi.org/10.1186/s12875-015-0344-4.Search in Google Scholar PubMed PubMed Central
49. McPhail, SM. Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Policy 2016:143–56.10.2147/RMHP.S97248Search in Google Scholar PubMed PubMed Central
50. Chamblee, RF. TRANSAX: the NCHS system for producing multiple cause-of-death statistics 1968-78. Vital and health statistics. Ser. 1, Programs and collection procedures. 1986;1–83. Available online: https://pubmed.ncbi.nlm.nih.gov/3765395/.Search in Google Scholar
51. Human Cause-of-Death Database. French institute for demographic studies (France) and max planck institute for demographic research (Germany). 2024. Available at: www.causeofdeath.org.Search in Google Scholar
52. McKenzie, DP, Thomas, C. Relative risks and odds ratios: simple rules on when and how to use them. Eur J Clin Invest 2020;50:e13249. Available: https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13249.10.1111/eci.13249Search in Google Scholar PubMed
53. Hidalgo, CA, Blumm, N, Barabási, AL, Christakis, NA. A dynamic network approach for the study of human phenotypes. PLoS Comput Biol 2009;5:e1000353. https://doi.org/10.1371/journal.pcbi.1000353.Search in Google Scholar PubMed PubMed Central
54. Morris, JA, Gardner, MJ. Statistics in medicine: calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J 1988;296:1313. https://doi.org/10.1136/bmj.296.6632.1313.Search in Google Scholar PubMed PubMed Central
55. Tallarida, RJ, Murray, RB, Tallarida, RJ, Murray, RB. Chi-square test. Manual of pharmacologic calculations: with computer programs. 1987;140–142 https://doi.org/10.1007/978-1-4612-4974-0_43.Search in Google Scholar
56. Chmiel, A, Klimek, P, Thurner, S. Spreading of diseases through comorbidity networks across life and gender. New J Phys 2014;16:115013. https://doi.org/10.1088/1367-2630/16/11/115013.Search in Google Scholar
57. Khan, A, Uddin, S, Srinivasan, U. Comorbidity network for chronic disease: a novel approach to understand type 2 diabetes progression. Int J Med Inf 2018;115:1–9. https://doi.org/10.1016/j.ijmedinf.2018.04.001.Search in Google Scholar PubMed
58. Kim, JH, Son, KY, Shin, DW, Kim, SH, Yun, JW, Shin, JH, et al.. Network analysis of human diseases using Korean nationwide claims data. J Biomed Inf 2016;61:276–82. https://doi.org/10.1016/j.jbi.2016.05.002.Search in Google Scholar PubMed
59. WHO. Multimorbidity: technical series on safer primary care. Geneva: World Health Organization; 2016. 2016. Licence: CC BY-NC-SA 3.0 IGO.Search in Google Scholar
Supplementary Material
This article contains supplementary material (https://doi.org/10.1515/em-2024-0033).
© 2025 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Causal mediation analysis for difference-in-difference design and panel data
- Research Articles
- Sensitivity analysis for unmeasured confounding for a joint effect with an application to survey data
- Investigating the association between school substance programs and student substance use: accounting for informative cluster size
- The quantiles of extreme differences matrix for evaluating discriminant validity
- Finite-sample improved confidence intervals based on the estimating equation theory for the modified Poisson and least-squares regressions
- What if dependent causes of death were independent?
- Bot invasion: protecting the integrity of online surveys against spamming
- A study of a stochastic model and extinction phenomenon of meningitis epidemic
- Understanding the impact of media and latency in information response on the disease propagation: a mathematical model and analysis
- Time-varying reproductive number estimation for practical application in structured populations
- Perspective
- Should we still use pointwise confidence intervals for the Kaplan–Meier estimator?
Articles in the same Issue
- Causal mediation analysis for difference-in-difference design and panel data
- Research Articles
- Sensitivity analysis for unmeasured confounding for a joint effect with an application to survey data
- Investigating the association between school substance programs and student substance use: accounting for informative cluster size
- The quantiles of extreme differences matrix for evaluating discriminant validity
- Finite-sample improved confidence intervals based on the estimating equation theory for the modified Poisson and least-squares regressions
- What if dependent causes of death were independent?
- Bot invasion: protecting the integrity of online surveys against spamming
- A study of a stochastic model and extinction phenomenon of meningitis epidemic
- Understanding the impact of media and latency in information response on the disease propagation: a mathematical model and analysis
- Time-varying reproductive number estimation for practical application in structured populations
- Perspective
- Should we still use pointwise confidence intervals for the Kaplan–Meier estimator?